Iodine (131 I) derlotuximab biotin
From WikiMD's WELLNESSPEDIA
| Iodine (131 I) derlotuximab biotin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 340013-96-9 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | |
Iodine (131 I) derlotuximab biotin is a monoclonal antibody designed for the treatment of recurrent glioblastoma multiforme.[1]
This drug was developed by Peregrine Pharmaceuticals, Inc.
References[edit]
 | This monoclonal antibody–related article is a stub. You can help WikiMD by expanding the page. |
